How long hives last from a medication allergy is a common concern for anyone experiencing an unexpected skin reaction to a drug. Drug-induced hives (urticaria) typically begin to improve within a few days of stopping the offending medication, with most acute episodes resolving within six weeks. However, duration varies depending on the drug involved, its half-life, and individual factors. This article explains what to expect, which medications most commonly cause allergic hives, how to manage symptoms safely, and when to seek urgent medical attention — with guidance aligned to NHS, NICE, and MHRA recommendations.

How Long Drug-Induced Hives Typically Last

Drug-induced hives usually begin to improve within a few days of stopping the causative medication, with acute episodes lasting up to six weeks; individual wheals typically fade within 24 hours, though new ones may appear during this period.

Drug-induced hives, medically known as urticaria, are one of the most common forms of allergic skin reaction to medication. Understanding how long they last depends largely on whether the reaction is acute or chronic, and how quickly the offending drug is identified and stopped.

In most cases, drug-induced hives begin to improve within a few days of discontinuing the causative medication, though the overall episode may last up to six weeks. Acute urticaria is defined as lasting fewer than six weeks. In some individuals — particularly those taking long-acting drugs, depot injections, or medications with a prolonged half-life — hives may persist for longer, as the drug continues to be active in the body even after the last dose.

Individual wheals — the raised, itchy welts characteristic of hives — typically come and go, with each individual wheal usually fading within 24 hours, though new ones may continue to appear for days. This pattern of transient, migratory welts is a hallmark feature that helps distinguish urticaria from other skin conditions.

If hives continue beyond six weeks despite stopping the suspected medication, this warrants evaluation for chronic spontaneous urticaria (CSU) or other underlying causes, and referral to a specialist should be considered. It is important to note that persistence beyond six weeks does not necessarily mean the drug is still responsible. If your hives are not following the typical pattern, or if they are accompanied by other symptoms, seek medical advice promptly.

Common Medications That Can Cause Allergic Hives

Antibiotics (especially penicillins), NSAIDs, ACE inhibitors, opioids, and anticonvulsants are among the most common causes of drug-induced hives; reactions can occur via IgE-mediated or non-immunological mechanisms.

A wide range of medications can trigger allergic hives, and it is important to be aware of the most frequently implicated drug classes. Reactions can occur through true immunological (IgE-mediated) mechanisms or through non-immunological pathways, such as direct mast cell activation.

Commonly implicated medications include:

• Antibiotics — particularly penicillins (e.g., amoxicillin) and cephalosporins, which are among the most frequent causes of drug-induced urticaria

• Non-steroidal anti-inflammatory drugs (NSAIDs) — such as ibuprofen and aspirin, which can trigger hives through inhibition of the COX-1 enzyme, altering arachidonic acid metabolism

• ACE inhibitors — such as ramipril and lisinopril; importantly, ACE inhibitor-related angioedema is typically bradykinin-mediated (not IgE-mediated) and may occur without hives. It requires urgent assessment and permanent discontinuation of the drug

• Opioid analgesics — such as codeine and morphine, which can directly stimulate mast cell degranulation

• Anticonvulsants — including carbamazepine and lamotrigine, which are associated with hypersensitivity reactions and, in rare cases, severe cutaneous adverse reactions (SCARs) such as Stevens–Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS). Red-flag features include blistering or peeling skin, mucosal involvement (mouth, eyes, or genitals), skin pain, target lesions, and fever or malaise. If any of these occur, stop the drug immediately and seek emergency care.

• Contrast media — used in radiological investigations, which can provoke urticarial reactions

• Monoclonal antibodies and vaccines — these can also trigger hypersensitivity reactions and should not be rechallenged without specialist input

It is also worth noting that over-the-counter medications, including certain herbal remedies and supplements, can cause hives. Patients should always inform their GP or pharmacist of all medications and supplements they are taking. Cross-reactivity between related drug classes (for example, between different penicillins) is clinically relevant and should be considered when prescribing alternative treatments.

Factors That Affect How Quickly Hives Clear Up

Drug half-life, route of administration, reaction severity, and individual immune response are the key factors determining how quickly drug-induced hives resolve after stopping the medication.

The speed at which drug-induced hives resolve is influenced by several clinical and individual factors. Understanding these can help set realistic expectations and guide appropriate management.

Key factors include:

• Drug half-life and elimination: Medications with a longer half-life remain active in the body for an extended period after the last dose, which can prolong the urticarial reaction. Biologics and drugs with very long half-lives are particularly relevant in this regard.

• Route of administration: Depot injections or long-acting formulations may cause prolonged reactions because the drug continues to be released slowly into the body after administration.

• Severity of the initial reaction: More severe or widespread urticaria may take longer to fully settle, even after the causative drug has been withdrawn.

• Individual immune response: Genetic factors, atopic history (such as asthma or eczema), and baseline immune function can all influence how the body responds and recovers.

• Concurrent medications: Some drugs may slow the metabolism of the offending agent via cytochrome P450 enzyme interactions, inadvertently prolonging exposure.

• Symptomatic treatment: Antihistamines, as recommended by NICE guidance, can help reduce itch and the frequency and severity of wheals, though they primarily provide symptom relief rather than shortening the overall course of the reaction.

In general, most uncomplicated drug-induced hives begin to improve within a few days of stopping the medication and starting appropriate treatment. If there is no improvement within 48–72 hours, reassessment by a healthcare professional is advisable.

Treatment Options Available in the UK

The cornerstone of treatment is stopping the causative drug; non-sedating antihistamines such as cetirizine or loratadine are the recommended first-line pharmacological option, with specialist referral for refractory cases.

Management of drug-induced hives in the UK follows guidance from NICE and the British Association of Dermatologists (BAD). The cornerstone of treatment is identifying and stopping the causative medication as soon as possible, in consultation with the prescribing clinician. Patients should never stop a prescribed medication without medical advice, particularly if it is essential for a serious condition.

First-line treatment involves non-sedating, second-generation oral antihistamines, such as:

• Cetirizine (10 mg once daily) — available over the counter

• Loratadine (10 mg once daily) — available over the counter

• Fexofenadine — 120 mg is available over the counter (licensed for hay fever); 180 mg is prescription-only and may be used for urticaria under clinician guidance

These are generally well tolerated. NICE guidance supports their use as the initial pharmacological approach for urticaria. If standard doses are insufficient, a clinician may recommend increasing the dose — up to four times the standard amount is sometimes used, but this is off-label and should only be undertaken under clinician or specialist supervision, typically in the context of chronic spontaneous urticaria.

For more severe or persistent cases, a short course of oral corticosteroids (such as prednisolone) may be prescribed by a GP to reduce inflammation and help manage symptoms. For symptomatic relief of itch, cooling measures such as cool compresses, loose clothing, and soothing preparations (e.g., calamine lotion or menthol-containing products) may be helpful alongside systemic treatment.

In cases of recurrent or chronic urticaria refractory to antihistamines, referral to a dermatologist or allergy specialist is appropriate. Specialist options include omalizumab (Xolair), a monoclonal antibody licensed in the UK for chronic spontaneous urticaria that has not responded adequately to H1-antihistamines, including at higher doses. Omalizumab is initiated and supervised by a specialist. Patients should also be advised to avoid known triggers and keep the skin cool to minimise discomfort during recovery.

When to Seek Urgent Medical Advice

Seek emergency care immediately if hives are accompanied by throat swelling, breathing difficulty, dizziness, or blistering skin, as these may indicate anaphylaxis or a severe cutaneous adverse reaction.

Experiencing these side effects? Our pharmacists can help you navigate them →

Whilst most cases of drug-induced hives are uncomfortable but not dangerous, certain features indicate a potentially serious or life-threatening reaction that requires immediate medical attention. It is essential that patients and carers are aware of these warning signs.

Seek emergency care (call 999 or go to A&E immediately) if you experience:

• Swelling of the lips, tongue, throat, or face (angioedema) — this can obstruct the airway

• Difficulty breathing, wheezing, or a tight chest

• Dizziness, light-headedness, or collapse

• Rapid or irregular heartbeat

• Nausea, vomiting, or abdominal cramping alongside hives

• Blistering or peeling skin, painful skin, target lesions, or involvement of the mouth, eyes, or genitals — these may indicate a severe cutaneous adverse reaction (SCAR) such as Stevens–Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), or DRESS, which are medical emergencies. Stop the suspected drug immediately and call 999 or attend A&E.

The first group of symptoms may indicate anaphylaxis, a severe, systemic allergic reaction that is a medical emergency. Anaphylaxis requires immediate treatment with intramuscular adrenaline (epinephrine), typically administered via an auto-injector (such as an EpiPen) if available, followed by emergency hospital care. Anyone who has been treated for suspected anaphylaxis should be referred to a specialist allergy service for assessment, and consideration should be given to prescribing an adrenaline auto-injector and providing a written emergency action plan (in line with NICE CG134).

Contact your GP or NHS 111 if:

• Hives are widespread, worsening, or not improving after 48–72 hours of stopping the medication

• You are unsure which medication is responsible

• You develop hives whilst taking a medication you cannot safely stop without medical guidance

• You have a history of severe allergic reactions

Patients who have experienced a significant drug allergic reaction should be referred for formal allergy assessment (in line with NICE CG183) and should carry documentation of their allergy. A MedicAlert bracelet or equivalent may be recommended for those at risk of future exposure.

Reporting a Medication Allergy Through the NHS and MHRA

Drug allergies should be documented in your NHS medical records by your GP, and suspected adverse reactions can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Reporting a suspected medication allergy is an important step in both personal safety and broader public health. In the UK, there are clear pathways for documenting and reporting adverse drug reactions.

Recording your allergy with the NHS: Your GP should update your medical records to clearly document any confirmed or suspected drug allergy, including the name of the medication, the nature of the reaction, and the date it occurred. This information is shared across NHS systems to help prevent future inadvertent prescribing of the same or related drugs. Patients are encouraged to proactively inform all healthcare providers — including dentists, pharmacists, and hospital teams — of known drug allergies at every point of care.

Reporting to the MHRA via the Yellow Card Scheme: The Medicines and Healthcare products Regulatory Agency (MHRA) operates the Yellow Card scheme, which allows both healthcare professionals and members of the public to report suspected adverse drug reactions, including allergic responses such as hives. Reports can be submitted:

• Online at yellowcard.mhra.gov.uk

• Via the Yellow Card app

Reporting is voluntary but strongly encouraged, as it contributes to ongoing pharmacovigilance and helps the MHRA identify previously unrecognised safety signals.

If you are uncertain whether your reaction constitutes a true allergy or an intolerance, your GP can refer you to an NHS allergy clinic for formal drug allergy assessment (in line with NICE CG183), which may include skin prick testing or a supervised drug challenge under specialist supervision.

Frequently Asked Questions